相关实验视频
Updated: Jan 10, 2026

09:41
Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
12.5K
YKT6通过通过USP7-介导的除化稳定β-catenin促进膀癌的进展
Sheng Tu1,2, Wenzhi Du3, Yongwen Luo1
1Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|November 26, 2025
概括
通过通过USP7稳定β-catenin,促进转移,YKT6蛋白驱动膀癌 (BLCA) 的进展. 针对YKT6/USP7/β-catenin轴为BLCA治疗提供了一个新的策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 膀癌 (BLCA) 是一种致命的恶性瘤,治疗选择有限.
- 了解BLCA的分子驱动因素对于开发有效疗法至关重要.
研究的目的:
- 研究YKT6,一个SNARE蛋白在膀癌进展中的作用.
- 阐明YKT6影响BLCA的分子机制.
- 探索向YKT6通路的治疗潜力.
主要方法:
- 使用公共数据集和组织微阵列分析BLCA组织和细胞系中YKT6表达的分析.
- 在体外和体外功能测试以评估YKT6对细胞增殖,迁移和转移的影响.
- 使用分子和生化技术研究YKT6,USP7和β-catenin之间的相互作用.
- 药理上抑制Wnt信号传递和USP7的基因淘汰,以验证该途径.
主要成果:
- 在BLCA中YKT6显著上调,与晚期瘤等级和不良预后相关.
- YKT6促进BLCA细胞的增殖,迁移和转移.
- YKT6激活了Wnt/β-catenin通路,通过招募USP7来使β-catenin脱并稳定.
- 抑制Wnt信号逆转YKT6驱动的瘤进展,USP7敲击取消YKT6的影响.
结论:
- 在膀癌中,YKT6通过调节YKT6/USP7/β-catenin轴作为瘤基因起作用.
- 这一轴代表了精密BLCA治疗的新型治疗目标.
- 准YKT6为改善膀癌患者的治疗结果提供了一个有希望的策略.
相关概念视频
Destabilization of Microtubules
3.4K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.4K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Anaphase Promoting Complex
3.3K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K
Catenins
3.0K
Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
3.0K
Canonical Wnt Signaling Pathway
10.4K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.4K

